| |
| | Treatment of Hemophilia and Other Bleeding Disorders: Monitoring the Blood Supply (Site not responding. Last check: 2007-10-21) |
 | | The CDC and the FDA are responsible for monitoring the blood supply for infectious agents that threaten its safety, while the NHLBI supports research to improve the safety and availability of blood and blood products. |
 | | Although the United States blood supply is safer than ever, concerns continue to arise about new infectious agents such as human herpes virus-8 (HHV-8, associated with Kaposi's sarcoma), Borna virus, variants of HIV-1, a new variant of the CJD agent, and a virus called TTV that may be associated with hepatitis. |
 | | For example, prevalence and incidence of newly discovered infectious agents can be estimated rapidly, the characteristics of populations at risk can be evaluated, and the impact of new screening methods can be assessed. |
| www.nhlbi.nih.gov /health/prof/blood/other/hemophilia/bloodsup.htm (365 words) |
|